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Abstract Sialic acids are essential components of cell surface
receptors used by influenza viruses. To determine the molecular
mechanisms of viral recognition of two major species of sialic
acids, N-acetylneuraminic acid (Neu5Ac) and N-glycolylneur-
aminic acid (Neu5Gc), we tested the binding reactivity of nine
human H3 influenza A viruses to sialylglycolipids containing type
II sugar chain and different molecular species of terminal sialic
acids. All human H3 viruses tested except A/Memphis/1/71
bound both Neu5Ac and Neu5Gc. Nucleotide sequence analysis
suggests that amino acids at 143, 155, and 158 are linked to the
viral recognition of Neu5Gc.
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1. Introduction
In£uenza virus infection is initiated by attachment of virus
to host cell receptors that are thought to be sialic acid con-
taining glycoproteins and glycolipids. Sialyl-oligosaccharide
moieties of cell surface glycoproteins and glycolipids exhibit
signi¢cant structural diversity, and numerous studies indicate
that the ability of sialic acid to serve as a receptor determinant
in£uenza virus may be in£uenced by the carbohydrate struc-
ture and sialic acid moiety of sialylglycoproteins [1^5], gan-
gliosides [6^9], or sialyl-oligosaccharides [10^13] to which it is
attached. There are about 30 derivatives of sialic acid in na-
ture [14]. Two major sialic acids are 5-N-acetylneuraminic
acid (Nue5Ac) and 5-N-glycolylneuraminic acid (Neu5Gc)
which are chemically distinguished by a functional group at
the C-5 position [15]. Neu5Gc is derived from Neu5Ac by
enzymatic hydroxylation of the N-acetyl group of CMP-
Neu5Ac [16^18]. Glycoconjugates containing Neu5Gc are
widely found in many animals [14], however they have not
yet been detected in normal human tissues. Understanding
the molecular mechanisms of sialic acid recognition will help
to clarify the roles of sialic acids on cell tropism and trans-
mission of viruses. Moreover, the observation would provide
useful information for development of anti-in£uenza virus
agents.
It was reported that the amino acid change at position 155
of hemagglutinin (HA) 1 from Thr to Tyr played a critical
role in the recognition of Neu5GcK2-6Gal [19]. Over the last
decade, we have examined the binding reactivity of in£uenza
A viruses isolated from various animal species by several virus
binding assays [2,6^9]. Recently, we found that equine and
swine in£uenza A viruses recognized glycolipids containing
Neu5GcK2-3Gal sequences [20,21]. The nucleotide sequences
of HA available in GenBank showed that amino acid Thr at
155 of HA1 was conserved in all equine strains tested, and
that the amino acid of swine in£uenza A viruses was Thr or
Tyr. In this report, we investigated the binding reactivity of
human H3 in£uenza A viruses to four types of sialylglyco-
lipids which had varied molecular species of terminal sialic
acids and sialyl linkage, and found that amino acid substitu-
tions at 143 and 158 are also linked to the viral recognition of
Neu5Gc.
2. Materials and method
2.1. Sialylglycolipids
The synthetic sialylglycolipids commonly had GalL1-4GlcNAcL1-
3GalL1-4Glc as a core structure, a sialic acid residue (Neu5Ac or
Neu5Gc) linked to a non-reducing galactose terminal, and the ceram-
ide portion substituted by a branched hydrocarbon chain containing
30 carbons (Table 1). All of the compounds were synthesized [22]
essentially by the procedure described by Kameyama et al. [23],
namely, glycosylation of the GlcNAcL1-3GalL1-4Glc acceptor [23]
with the Neu5AcK2-3Gal [23], Neu5AcK2-6Gal [24], Neu5GcK2-
3Gal [25], and Neu5GcK2-6Gal donors, and subsequent introduction
of the lipid tail to the reducing end [26].
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2.2. Viruses
Seeds of all in£uenza A viruses were gifts from the Department of
Disease Control, Graduate School of Veterinary Medicine, Hokkaido
University and the Department of Virology and Molecular Biology,
St. Jude Children’s Research Hospital. Viruses were grown in 10-day-
old embryonated chicken eggs and were puri¢ed by sucrose density
gradient centrifugation. Viral hemagglutination units (HAU) were de-
termined at 4‡C in microtiter plates as previously described [6].
2.3. Binding assay
The binding reactivity of in£uenza A viruses to sialic acid-contain-
ing glycolipids was examined by thin-layer chromatography (TLC)/
virus binding assay. Synthetic sialylglycolipids (500 pmol) were devel-
oped in silica gel TLC plates by chloroform/methanol/12 mM aqueous
MgCl2 (5/4/1, v/v). TLC plates were immersed in phosphate bu¡ered
saline containing 1% egg albumin and 1% polyvinylpyrrolidone. TLC
plates were then overlaid with in£uenza virus suspension (28 HAU)
for 12^16 h at 4‡C. TLC plates were incubated with rabbit anti-in£u-
enza virus antiserum, followed by horseradish peroxidase-conjugated
protein A. Finally, the plates were visualized as described in [20].
2.4. Sequence determination
To determine the nucleotide sequences, RT-PCR was performed.
HA genes of in£uenza viruses were ampli¢ed using the primers
5PH3 (5P-AGCAAAAGCAGGGGATAA-3P, sense) and 3PH3 (5P-
TGTTGCACCTAATGTTGC03P, antisense). PCR products from vi-
ruses were sequenced with an automatic sequencer (Applied Biosys-
tems Inc.).
3. Results and discussion
We investigated the binding reactivity of nine human H3
in£uenza A viruses to four types of synthetic sialylglycolipids
which had varied molecular species of terminal sialic acids
and sialyl linkages, such as Neu5AcK2-3Gal, Neu5AcK2-
6Gal, Neu5GcK2-3Gal and Neu5GcK2-6Gal (Table 1). All
human H3 in£uenza A virus strains recognized the Neu5-
AcK2-6Gal linkage more strongly than Neu5AcK2-3Gal as
described previously [3,4,27^29]. Eight strains bound glycolip-
ids containing both types of sialic acid residues, Neu5AcK2-
6Gal and Neu5GcK2-6Gal. On the other hand, A/Memphis/1/
71 (H3N2) bound only glycolipids containing Neu5Ac, but
not Neu5Gc (Fig. 1). In further experiments, we carried out
TLC/virus binding assays with various concentrations of syn-
thetic glycolipids (500^1500 pmol) and a high concentration
of the virus (212 HAU). In both cases, A/Memphis/1/71
showed no binding to glycolipids containing Neu5Gc (data
not shown). To investigate the amino acid residues of HA
involved in recognition of Neu5Gc, we determined the nucleo-
tide sequences of all tested in£uenza viruses including A/To-
kyo/6/73, A/Kumamoto/55/76 and A/Yamanashi/2/77 which
were not available in the GenBank data base. Fig. 2 shows
the deduced amino acid sequences of HA1. We noticed that
the amino acids of HA were similar between A/Aichi/2/68 and
A/Memphis/1/71, but binding reactivities to Neu5Gc were dif-
ferent. We compared the amino acid sequence of HA1 of A/
Memphis/1/71 with that of A/Aichi/2/68. The sequences were
almost identical except for seven changes at positions 2, 31,
78, 143, 144, 158, and 319. However, both viruses had con-
served Thr-155. We assume that amino acids which vary from
A/Memphis/1/71 to A/Aichi/2/68 will a¡ect the ability to bind
Neu5Gc.
Fig. 1. Binding reactivity of in£uenza A viruses to sialylglycolipids
was determined as described in Section 2 by the TLC/virus binding
assay. A: A/Memphis/1/71 (H3N2); B: A/Aichi/2/68 (H3N2); C:
A/Hongkong/1/68 (H3N2); D: A/Memphis/102/72 (H3N2); E:
A/Tokyo/6/73 (H3N2); F: A/Kumamoto/55/76 (H3N2); G: A/Ya-
manashi/2/77 (H3N2); H: A/Texas/1/77(H3N2); I: A/Bangkok/1/79
(H3N2); J: no virus; K: chemical staining sprayed orcinol. Lanes:
1, IV3(Neu5Ac)nLc4B30; 2, IV6(Neu5Ac)nLc4B30; 3, IV3(Neu5Gc)-
nLc4B30; 4, IV6(Neu5Gc)nLc4B30.
Fig. 2. The deduced amino acid sequences of HA1 regions were de-
termined. The single letter codes for amino acids are used. Boxed
indicates receptor binding site. The amino acids at positions 155,
158 and 143 are shown in bold.
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The tertiary structure of the in£uenza A virus HA (X-31)
complexed with sialic acid has already been elucidated
[12,30,31]. The receptor binding site (RBS) was a depression,
the bottom of which is formed by the phenolic hydroxy group
of Tyr-98 and aromatic rings of Trp-153. Gln-190 and Leu-
194 project down from a short helix to de¢ne the rear of the
site with His-183 and Thr-155. Amino acid residues 134^138
form the right side and residues 224^228 form the left side of
the binding site (Fig. 3).
The amino acid residues at 2, 31, 78, and 319 of HA are
distant from the RBS. Thus, we did not think that these
amino acid changes a¡ect the recognition of Neu5Gc. The
amino acids at 143, 144 and 158 do not take part in RBS,
but are located near the RBS. To understand the in£uence of
these amino acids in recognition, we compared the amino acid
sequence of A/Memphis/1/71 with that of the other H3 viruses
tested. In other viruses, His-143 was replaced by Pro or Ser.
Gly-144 was substituted by Asp but was preserved in A/Hong-
kong/1/68 which could recognize both types of sialic acid res-
idues. These data suggest that the amino acid at 143 in HA
a¡ects the recognition of Neu5Gc. As to the amino acid at
position 158, Glu-158 was preserved in A/Bangkok/1/79 and
A/Texas/1/77, but was changed in other virus strains. How-
ever, the binding reactivity of A/Memphis/1/71 di¡ered from
the binding reactivity of A/Bangkok/1/79 and A/Texas/1/71. A
previous study showed that amino acid substitution at posi-
tion 155 from Thr to Tyr played a critical role in recognition
of Neu5Gc [19]. Viruses isolated after 1972 showed the ability
to bind Neu5Gc, because these strains have Tyr-155 in HA.
A/Aichi/2/68 and A/Hongkong/1/68 bound Neu5Gc-contain-
ing glycolipids, although they were isolated before 1972. In
these viruses, Gly-158 played a critical role in recognition of
Neu5Gc. We suppose that the amino acid at position 158
in£uences the structural features around this position of
RBS. These data indicate that not only the amino acid at
Fig. 3. Amino acids in the RBS of in£uenza H3 virus are shown on
the model of the X-31 HA complexed with Neu5Ac. Yellow atoms
are the receptor binding site (98, 153, 155, 190, 194); blue atoms
are the left side of the receptor binding site (134^138); green atoms
are the right site of the receptor binding site (224^228); the amino
acid at position 155 is red; the amino acid at 158 is orange; the
amino acid at 143 is purple. The amino acids at 158 and 143 are lo-
cated close to the RBS, and in£uenced the recognition of Neu5Gc.
This ¢gure is based on the H3 HA structure of X-31 (H3N2) com-
plexed with sialic acid (PDB ID: 1HGG structure) as determined by
Sauter et al. [30].
Table 1
Carbohydrate structures of synthetic glycolipids
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155 but also those at 143 and 158 are linked to the viral
recognition of Neu5Gc.
Our ¢ndings disagree with a previous study. Anders et al.
reported that human H3 in£uenza A viruses isolated before
1972 did not bind Neu5GcK2-6Gal-containing glycoprotein
[19]. On the other hand, our ¢ndings indicated that A/Aichi/
2/68 and A/Hongkong/1/68, which were isolated before 1972,
bound Neu5GcK2-6Gal-carrying glycolipids.
We excluded the possibility that either another strain of
in£uenza virus had contaminated our preparation of A/Ai-
chi/2/68, or point-mutated viruses generated during the prop-
agation of A/Aichi/2/68 had overcome the original strain. The
pattern of binding reactivity to each sialic acid-containing
oligosaccharide was identical between cloned viruses and the
originals. Comparing the nucleotide sequences of the cloned
viruses, the HA1 amino acid sequences of all viruses were
identical to the sequence obtained from the GenBank data
base (accession number J02090) except for the amino acids
at positions 144 and 182. Our result clearly showed that A/
Aichi/2/68 exhibited the same binding reactivity of Neu5Gc as
other virus strains that were never contaminated. Anders et al.
[19] examined the binding reactivity of in£uenza viruses to
Neu5Gc by a hemagglutination assay using erythrocytes
whose oligosaccharides were modi¢ed by sialyltransferases.
Conversely, we used a TLC/binding assay with de¢ned sialyl-
glycolipids which contained di¡erent molecular species of
sialic acid residues and di¡erent sialyl linkages. A previous
study indicated that the structure and length of core oligosac-
charides or diversity of oligosaccharides a¡ected the binding
activity of the viruses [32]. The sialylglycolipids we used have
a lacto-series type II chain, GalL1-4GlcNAcL1-3GalL1-4Glc.
The structure of core oligosaccharides on the surface of eryth-
rocytes modi¢ed with sialyltransferases was unknown. These
structural di¡erences may a¡ect viral recognition. Recently,
M protein was correlated with the binding reactivity of HA
of in£uenza A virus (H1N1) [33]. In the case of H3 viruses,
during propagation in eggs, mutations in M protein as well as
HA may a¡ect the recognition of receptor oligosaccharides.
To further investigate the involvement of other proteins, it
will be necessary to employ di¡erent approaches such as as-
says using recombinant particles expressing HA.
In this study, we demonstrated that not only the amino acid
at position 155 but also the amino acids at 143 and 158 of
HA1 of in£uenza viruses in the vicinity of RBS a¡ect binding
reactivity to the molecular species of sialic acid (Neu5Ac,
Neu5Gc). This ¢nding will be helpful in understanding the
signi¢cance of molecular species of sialic acid for viral trans-
mission and host range restriction.
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